Multiple breath washout is feasible in the clinical setting and detects abnormal lung function in infants and young children with cystic fibrosis

Respiration

Volumn 87, Issue 5, 2014, Pages 357-363

  Stahl, Mirjam ^a   Joachim, Cornelia ^a   Blessing, Kerstin ^a   Hämmerling, Susanne ^a   Sommerburg, Olaf ^a   Latzin, Philipp ^b   Mall, Marcus A ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

Author keywords

Cystic fibrosis lung disease; Infants; Lung clearance index; Preschool children; Pulmonary function test

Indexed keywords

CHLORAL HYDRATE; SULFUR HEXAFLUORIDE;

ARTICLE; BREATHING; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; CYSTIC FIBROSIS; FEMALE; HUMAN; LUNG CLEARANCE; LUNG FUNCTION; LUNG FUNCTION TEST; MALE; MULTIPLE BREATH WASHOUT; PRIORITY JOURNAL; PROSPECTIVE STUDY; BODY WEIGHT; BREATH ANALYSIS; BREATHING PATTERN; COMPARATIVE STUDY; DISEASE DURATION; FEASIBILITY STUDY; HAEMOPHILUS INFLUENZAE; INFANT; LUNG MINUTE VOLUME; MEDICAL EXAMINATION; NEWBORN; NOSE SMEAR; NUCLEAR MAGNETIC RESONANCE IMAGING; OXYGEN SATURATION; PEDIATRICS; PULSE OXIMETRY; SCORING SYSTEM; SEDATION; STAPHYLOCOCCUS AUREUS; THROAT CULTURE; CASE CONTROL STUDY; DIAGNOSTIC USE; LUNG; PATHOPHYSIOLOGY; PRESCHOOL CHILD; PROCEDURES;

BREATH TESTS; CASE-CONTROL STUDIES; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; CYSTIC FIBROSIS; FEASIBILITY STUDIES; FEMALE; HUMANS; INFANT; LUNG; MALE; PROSPECTIVE STUDIES; SULFUR HEXAFLUORIDE;

EID: 84899898309     PISSN: 00257931     EISSN: 14230356     Source Type: Journal    
DOI: 10.1159/000357075     Document Type: Article

References (35)

1. Mall M, Boucher RC: Pathogenesis of pulmonary disease in cystic fibrosis; in Bush A (ed): Cystic Fibrosis in the 21st Century. Basel, Karger, 2006, vol 34, pp 116-121.
2. Gibson RL, Burns JL, Ramsey BW: Pathophysiology and management of pulmonary infections in cystic fibrosis. Am J Respir Crit Care Med 2003; 168: 918-951.
3. Belessis Y, Dixon B, Hawkins G, Pereira J, Peat J, MacDonald R, Field P, Numa A, Morton J, Lui K, Jaffe A: Early cystic fibrosis lung disease detected by bronchoalveolar lavage and lung clearance index. Am J Respir Crit Care Med 2012; 185: 862-873.
4. Hoo AF, Thia LP, Nguyen TT, Bush A, Chudleigh J, Lum S, Ahmed D, Lynn IB, Carr SB, Chavasse RJ, Costeloe KL, Price J, Shankar A, Wallis C, Wyatt HA, Wade A, Stocks J: Lung function is abnormal in 3-month-old infants with cystic fibrosis diagnosed by newborn screening. Thorax 2012; 67: 874-881.
5. Sly PD, Brennan S, Gangell C, de Klerk N, Murray C, Mott L, Stick SM, Robinson PJ, Robertson CF, Ranganathan SC: Lung disease at diagnosis in infants with cystic fibrosis detected by newborn screening. Am J Respir Crit Care Med 2009; 180: 146-152.
6. Stick SM, Brennan S, Murray C, Douglas T, von Ungern-Sternberg BS, Garratt LW, Gangell CL, De Klerk N, Linnane B, Ranganathan S, Robinson P, Robertson C, Sly PD: Bronchiectasis in infants and preschool children diagnosed with cystic fibrosis after newborn screening. J Pediatr 2009; 155: 623.e1-628.e1.
7. Peterson-Carmichael SL, Harris WT, Goel R, Noah TL, Johnson R, Leigh MW, Davis SD: Association of lower airway inflammation with physiologic findings in young children with cystic fibrosis. Pediatr Pulmonol 2009; 44: 503-511.
8. Lum S, Gustafsson P, Ljungberg H, Hulskamp G, Bush A, Carr SB, Castle R, Hoo AF, Price J, Ranganathan S, Stroobant J, Wade A, Wallis C, Wyatt H, Stocks J: Early detection of cystic fibrosis lung disease: multiple-breath washout versus raised volume tests. Thorax 2007; 62: 341-347.
9. Ramsey BW, Banks-Schlegel S, Accurso FJ, Boucher RC, Cutting GR, Engelhardt JF, Guggino WB, Karp CL, Knowles MR, Kolls JK, LiPuma JJ, Lynch S, McCray PB Jr, Rubenstein RC, Singh PK, Sorscher E, Welsh M: Future directions in early cystic fibrosis lung disease research: an NHLBI workshop report. Am J Respir Crit Care Med 2012; 185: 887-892.
10. Beydon N, Davis SD, Lombardi E, Allen JL, Arets HG, Aurora P, Bisgaard H, Davis GM, Ducharme FM, Eigen H, Gappa M, Gaultier C, Gustafsson PM, Hall GL, Hantos Z, Healy MJ, Jones MH, Klug B, Lodrup Carlsen KC, McKenzie SA, Marchal F, Mayer OH, Merkus PJ, Morris MG, Oostveen E, Pillow JJ, Seddon PC, Silverman M, Sly PD, Stocks J, Tepper RS, Vilozni D, Wilson NM: An official American Thoracic Society/European Respiratory Society statement: pulmonary function testing in preschool children. Am J Respir Crit Care Med 2007; 175: 1304-1345.
11. Aurora P: Multiple-breath washout in preschool children-FRC and ventilation inhomogeneity. Paediatr Respir Rev 2006; 7(suppl 1): S14-S16.
12. Horsley AR, Gustafsson PM, Macleod KA, Saunders C, Greening AP, Porteous DJ, Davies JC, Cunningham S, Alton EW, Innes JA: Lung clearance index is a sensitive, repeatable and practical measure of airways disease in adults with cystic fibrosis. Thorax 2008; 63: 135-140.
13. Kraemer R, Blum A, Schibler A, Ammann RA, Gallati S: Ventilation inhomogeneities in relation to standard lung function in patients with cystic fibrosis. Am J Respir Crit Care Med 2005; 171: 371-378.
14. Singer F, Kieninger E, Abbas C, Yammine S, Fuchs O, Proietti E, Regamey N, Casaulta C, Frey U, Latzin P: Practicability of nitrogen multiple-breath washout measurements in a pediatric cystic fibrosis outpatient setting. Pediatr Pulmonol 2013; 48: 739-746.
15. Ellemunter H, Fuchs SI, Unsinn KM, Freund MC, Waltner-Romen M, Steinkamp G, Gappa M: Sensitivity of lung clearance index and chest computed tomography in early CF lung disease. Respir Med 2010; 104: 1834-1842.
16. Hirtz S, Gonska T, Seydewitz HH, Thomas J, Greiner P, Kuehr J, Brandis M, Eichler I, Rocha H, Lopes AI, Barreto C, Ramalho A, Amaral MD, Kunzelmann K, Mall M: CFTR Cl-channel function in native human colon correlates with the genotype and phenotype in cystic fibrosis. Gastroenterology 2004; 127: 1085-1095.
17. Sommerburg O, Lindner M, Muckenthaler M, Kohlmueller D, Leible S, Feneberg R, Kulozik AE, Mall MA, Hoffmann GF: Initial evaluation of a biochemical cystic fibrosis newborn screening by sequential analysis of immunoreactive trypsinogen and pancreatitis-associated protein (IRT/PAP) as a strategy that does not involve DNA testing in a Northern European population. J Inherit Metab Dis 2010; 33:S263-S271.
18. Brandt I, Reinken L: The growth rate of healthy children in the first 16 years: Bonn-Dortmund longitudinal developmental study (in German). Klin Padiatr 1988; 200: 451-456.
19. Kromeyer-Hauschild K, Wabitsch M, Geller F, Ziegler A, Geiss HC, Hesse V, Hippel V, Jaeger U, Johnsen D, Kiess W, Korte W, Kunze D, Menner K, Muller M, Niemann-Pilatus A, Remer TH, Schaefer F, Wittchen HU, Zabransky S, Zellner K, Hebebrand J: Perzentile fur den Body Mass Index fur das Kindesund Jugendalter unter Heranziehung verschiedener deutscher Stichproben. Monatschr Kinderheilkd 2001; 149: 807-818.
20. Fuchs O, Latzin P, Thamrin C, Stern G, Frischknecht P, Singer F, Kieninger E, Proietti E, Riedel T, Frey U: Normative data for lung function and exhaled nitric oxide in unsedated healthy infants. Eur Respir J 2011; 37: 1208-1216.
21. American Academy of Pediatrics Committee on Drugs and Committee on Environmental Health: use of chloral hydrate for sedation in children. Pediatrics 1993; 92: 471-473.
22. Gaultier C, Fletcher ME, Beardsmore C, England S, Motoyama E: Respiratory function measurements in infants: measurement conditions-Working Group of the European Respiratory Society and the American Thoracic Society. Eur Respir J 1995; 8: 1057-1066.
23. Latzin P, Sauteur L, Thamrin C, Schibler A, Baldwin D, Hutten GJ, Kyburz M, Kraemer R, Riedel T, Frey U: Optimized temperature and deadspace correction improve analysis of multiple breath washout measurements by ultrasonic flowmeter in infants. Pediatr Pulmonol 2007; 42: 888-897.
24. Kieninger E, Singer F, Fuchs O, Abbas C, Frey U, Regamey N, Casaulta C, Latzin P: Longterm course of lung clearance index between infancy and school-age in cystic fibrosis subjects. J Cyst Fibros 2011; 10: 487-490.
25. Robinson PD, Latzin P, Verbanck S, Hall GL, Horsley A, Gappa M, Thamrin C, Arets HG, Aurora P, Fuchs SI, King GG, Lum S, Macleod K, Paiva M, Pillow JJ, Ranganathan S, Ratjen F, Singer F, Sonnappa S, Stocks J, Subbarao P, Thompson BR, Gustafsson PM: Consensus statement for inert gas washout measurement using multiple-and single-breath tests. Eur Respir J 2013; 41: 507-522.
26. Bakker EM, van der Meijden JC, Nieuwhof EM, Hop WC, Tiddens HA: Determining presence of lung disease in young children with cystic fibrosis: lung clearance index, oxygen saturation and cough frequency. J Cyst Fibros 2012; 11: 223-230.
27. Hall GL, Logie KM, Parsons F, Schulzke SM, Nolan G, Murray C, Ranganathan S, Robinson P, Sly PD, Stick SM, Berry L, Garratt L, Massie J, Mott L, Poreddy S, Simpson S: Air trapping on chest CT is associated with worse ventilation distribution in infants with cystic fibrosis diagnosed following newborn screening. PLoS One 2011; 6:e23932.
28. Amin R, Subbarao P, Jabar A, Balkovec S, Jensen R, Kerrigan S, Gustafsson P, Ratjen F: Hypertonic saline improves the LCI in paediatric patients with CF with normal lung function. Thorax 2010; 65: 379-383.
29. Amin R, Subbarao P, Lou W, Jabar A, Balkovec S, Jensen R, Kerrigan S, Gustafsson P, Ratjen F: The effect of dornase alfa on ventilation inhomogeneity in patients with cystic fibrosis. Eur Respir J 2011; 37: 806-812.
30. Mall M, Grubb BR, Harkema JR, O'Neal WK, Boucher RC: Increased airway epithelial Na + absorption produces cystic fibrosis-like lung disease in mice. Nat Med 2004; 10: 487-493.
31. Zhou Z, Duerr J, Johannesson B, Schubert SC, Treis D, Harm M, Graeber SY, Dalpke A, Schultz C, Mall MA: The ENaC-overexpressing mouse as a model of cystic fibrosis lung disease. J Cyst Fibros 2011; 10(suppl 2):S172-S182.
32. Zhou Z, Treis D, Schubert SC, Harm M, Schatterny J, Hirtz S, Duerr J, Boucher RC, Mall MA: Preventive but not late amiloride therapy reduces morbidity and mortality of lung disease in βENaC-overexpressing mice. Am J Respir Crit Care Med 2008; 178: 1245-1256.
33. Rosenfeld M, Ratjen F, Brumback L, Daniel S, Rowbotham R, McNamara S, Johnson R, Kronmal R, Davis SD: Inhaled hypertonic saline in infants and children younger than 6 years with cystic fibrosis: the ISIS randomized controlled trial. JAMA 2012; 307: 2269-2277.
34. Subbarao P, Stanojevic S, Brown M, Jensen R, Rosenfeld M, Davis S, Brumback L, Gustafsson P, Ratjen F: Lung clearance index as an outcome measure for clinical trials in young children with cystic fibrosis: a pilot study using inhaled hypertonic saline. Am J Respir Crit Care Med 2013; 188: 456-460.
35. Ranganathan SC, Goetz I, Hoo AF, Lum S, Castle R, Stocks J: Assessment of tidal breathing parameters in infants with cystic fibrosis. Eur Respir J 2003; 22: 761-766.